From circuits to behavior: Amygdala dysfunction in fragile X syndrome

被引:1
|
作者
Svalina, Matthew N. N. [1 ,2 ,3 ,4 ]
Sullivan, Regina [5 ,6 ]
Restrepo, Diego [2 ,4 ]
Huntsman, Molly M. M. [2 ,3 ,7 ]
机构
[1] Univ Colorado, Med Scientist Training Program, Anschutz Med Campus, Aurora, CO USA
[2] Univ Colorado, Neurosci Grad Program, Anschutz Med Campus, Aurora, CO 80045 USA
[3] Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA
[4] Univ Colorado, Dept Cell & Dev Biol, Anschutz Med Campus, Aurora, CO USA
[5] Nathan S Kline Inst Psychiat Res, Brain Inst, Orangeburg, NY USA
[6] NYU, Child Study Ctr, Sch Med, Child & Adolescent Psychiat, New York, NY USA
[7] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO 80045 USA
来源
FRONTIERS IN INTEGRATIVE NEUROSCIENCE | 2023年 / 17卷
关键词
critical period; synaptic plasticity; basolateral amygdala; fragile X syndrome; development; E/I balance; MENTAL-RETARDATION PROTEIN; CRITICAL-PERIOD PLASTICITY; MESSENGER-RNA TRANSLATION; LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; MOUSE MODEL; GABAERGIC INTERNEURONS; GABA(A) RECEPTOR; CONDITIONED FEAR; BRAIN-STEM;
D O I
10.3389/fnint.2023.1128529
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a repeat expansion mutation in the promotor region of the FMR1 gene resulting in transcriptional silencing and loss of function of fragile X messenger ribonucleoprotein 1 protein (FMRP). FMRP has a well-defined role in the early development of the brain. Thus, loss of the FMRP has well-known consequences for normal cellular and synaptic development leading to a variety of neuropsychiatric disorders including an increased prevalence of amygdala-based disorders. Despite our detailed understanding of the pathophysiology of FXS, the precise cellular and circuit-level underpinnings of amygdala-based disorders is incompletely understood. In this review, we discuss the development of the amygdala, the role of neuromodulation in the critical period plasticity, and recent advances in our understanding of how synaptic and circuit-level changes in the basolateral amygdala contribute to the behavioral manifestations seen in FXS.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] The State of Synapses in Fragile X Syndrome
    Pfeiffer, Brad E.
    Huber, Kimberly M.
    NEUROSCIENTIST, 2009, 15 (05) : 549 - 567
  • [32] Auditory processing in fragile X syndrome
    Rotschafer, Sarah E.
    Razak, Khaleel A.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [33] Pathological Plasticity in Fragile X Syndrome
    Martin, Brandon S.
    Huntsman, Molly M.
    NEURAL PLASTICITY, 2012, 2012
  • [34] An "Omic" Overview of Fragile X Syndrome
    Dionne, Olivier
    Corbin, Francois
    BIOLOGY-BASEL, 2021, 10 (05):
  • [35] Molecular Biomarkers in Fragile X Syndrome
    Zafarullah, Marwa
    Tassone, Flora
    BRAIN SCIENCES, 2019, 9 (05)
  • [36] Translational endpoints in fragile X syndrome
    de Esch, Celine E. F.
    Zeidler, Shimriet
    Willemsen, Rob
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2014, 46 : 256 - 269
  • [37] Advances in the Treatment of Fragile X Syndrome
    Hagerman, Randi J.
    Berry-Kravis, Elizabeth
    Kaufmann, Walter E.
    Ono, Michele Y.
    Tartaglia, Nicole
    Lachiewicz, Ave
    Kronk, Rebecca
    Delahunty, Carol
    Hessl, David
    Visootsak, Jeannie
    Picker, Jonathan
    Gane, Louise
    Tranfaglia, Michael
    PEDIATRICS, 2009, 123 (01) : 378 - 390
  • [38] Targeted treatments in fragile X syndrome
    Hare, Emma B.
    Hagerman, Randi J.
    Lozano, Reymundo
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (06): : 531 - 543
  • [39] Modeling Fragile X Syndrome in Drosophila
    Drozd, Malgorzata
    Bardoni, Barbara
    Capovilla, Maria
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2018, 11
  • [40] Fragile X syndrome: From targets to treatments
    Wijetunge, Lasani S.
    Chattarji, Sumantra
    Wyllie, David J. A.
    Kind, Peter C.
    NEUROPHARMACOLOGY, 2013, 68 : 83 - 96